Dynavax are leaders in utilizing the innate immune system on behalf of patients to address unmet clinical needs. They are committed to a rigorous approach to drug development in the field of TLR biology and immune system modulation to attack the challenges of infectious and inflammatory diseases and cancer. Their corporate values are the collective ideals and ethical standards that they hold dear. These values provide the foundation of their culture and how they operate as a company. Dynavax is driven to make a difference by innovating immunology to discover new treatment options to improve patients’ lives.